Table 3.xls (5.5 kB)
Non-serious adverse events reported by participants in the two treatment groups.
dataset
posted on 2019-11-21, 18:58 authored by Gabriel Arteaga-Troncoso, Aide E. Chacon-Calderon, Francisco J. Martinez-Herrera, Sylvia G. Cruz-Nuñez, Marcela Lopez-Hurtado, Aurora Belmont-Gomez, Alberto M. Guzman-Grenfell, Blanca E. Farfan-Labonne, Carlos J. Neri-Méndez, Francisco Zea-Prado, Fernando M. Guerra-InfanteNon-serious adverse events reported by participants in the two treatment groups.
History
Usage metrics
Categories
Keywords
isosorbide dinitrate-oxytocinisosorbide dinitratefoetal expulsion rateisosorbide dinitrate-oxytocin groupmisoprostol-oxytocinfoetal deathIUFDintravaginal isosorbide dinitratedelivery induction interval20 weeksisosorbide dinitrate-oxytocin combinationTrial registration Clinicaltrials.gov NCT 02488642
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC